Jaguar health to host scientific discussion about cancer therapy-related diarrhea in breast cancer and the company's ongoing ontarget pivotal phase 3 trial at san antonio breast cancer symposium (sabcs 2021)

Content from the discussion will be featured in upcoming "diarrhea dialogues: part 2" san francisco, ca / accesswire / december 6, 2021 / jaguar health, inc. (nasdaq:jagx) today announced it is hosting a closed satellite event on december 9, 2021 at sabcs in san antonio, texas. the evening includes a discussion with leading oncologists on the debilitating effects of diarrhea experienced as a result of cancer and/or cancer therapy.
JAGX Ratings Summary
JAGX Quant Ranking